Guizhou Xinbang Pharmaceutical Co.,Ltd.’s Net Profit Rose 14.1% in First Three Quarters of 2022

Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 276.7 million yuan in the first three quarters of 2022, up 14.1% year-on-year.

Meanwhile, the company posted 4.7 billion yuan in revenue, down 0.8% year-on-year.

At the end of the reporting period, it had 10 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 29.5%.